Overview
Atlas Data Storage turns binary data into DNA by encoding it in the A, C, G, T sequence and stores the data as dry powder in rugged steel capsules. It leverages a silicon-based semiconductor platform licensed from Twist Bioscience to miniaturize DNA synthesis and enable massively parallel chemistry on a chip. The company sells data archival services to enterprises, including hyperscalers, government agencies, and regulated sectors, and launched Atlas Eon 100 in December 2025 for permanent data preservation. Its approach combines high data density, long-term durability with air-gap security, and end-to-end archival solutions to reduce maintenance and migration compared with traditional media, aiming to enable scalable, permanent data storage for large-scale archives.
Work here?Claim your company
Simplify's take
What believers are saying
- Atlas launched Eon 100 on December 2, 2025, as its first scalable service.
- imec invested on March 5, 2026, adding R&D, fabrication, and business support.
- TSMC invited Atlas to its April 22, 2026 symposium, signaling ecosystem credibility.
What critics are saying
- SNIA expects DNA archival scale only after 2028, delaying meaningful revenue.
- Atlas publishes no independent performance data; Imperial College's Thomas Heinis criticized that gap.
- Biomemory's March 2026 Catalog acquisition tightens competition for scarce enterprise archive buyers.
What makes Atlas Data Storage unique
- Atlas pairs Twist's silicon DNA synthesis license with CMOS semiconductor workflows.
- Atlas Eon 100 stores DNA in powder-filled steel capsules for air-gapped transport.
- imec and TSMC 2026 endorsements validate Atlas's semiconductor-biotech integration.
Help us improve and share your feedback! Did you find this helpful?